Medicare Enrolled
Dr. Morris Naus, M.D.
Gastroenterology · Delray Beach, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Naus from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Naus?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Naus
Dr. Morris Naus is a gastroenterology specialist in Delray Beach, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Naus performed 37,950 Medicare services across 2,005 unique beneficiaries.
Between the years covered by Open Payments, Dr. Naus received a total of $198,703 from 60 pharmaceutical and/or device companies across 1052 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Naus is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 0% volume in FL
$198,703 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 73948 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary
Medicare Utilization ↗37,950
Medicare services
Top 0% in FL for gastroenterology
2,005
Unique beneficiaries
$23
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,898 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Vedolizumab infusion (Entyvio) This procedure involves the administration of vedolizumab via injection. The dosage is measured in milligrams. |
33,600 | $17 | $52 |
| Infliximab infusion (Remicade) An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose. |
1,900 | $26 | $231 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
520 | $64 | $237 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
397 | $96 | $348 |
| Upper GI endoscopy with biopsy A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities. |
277 | $78 | $1,175 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
152 | $99 | $344 |
| Colonoscopy for colorectal cancer screening, high risk A colonoscopy performed to screen for colorectal cancer in individuals identified as being at high risk for the disease. |
136 | $191 | $1,089 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
117 | $53 | $223 |
| Colon polyp removal with endoscopic snare This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination. |
101 | $217 | $1,426 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
85 | $145 | $670 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
67 | $124 | $542 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
60 | $8 | $9 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
52 | $80 | $358 |
| Colonoscopy A diagnostic exam of the large bowel using a flexible endoscope to visualize the interior of the colon. |
51 | $144 | $1,491 |
| Colonoscopy with biopsy A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease. |
50 | $143 | $1,497 |
| Dilation of esophagus | 48 | $37 | $714 |
| Upper endoscopy (EGD) A diagnostic exam of the esophagus, stomach, and upper small bowel using a flexible endoscope. |
43 | $90 | $982 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
43 | $12 | $81 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
42 | $1 | $5 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
40 | $107 | $1,000 |
| External hemorrhoid removal by rubber banding A procedure to remove external hemorrhoids using rubber bands to cut off blood supply. The affected tissue is tied off and eventually falls off. |
37 | $227 | $903 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
37 | $44 | $142 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
36 | $65 | $237 |
| Colonoscopy for colorectal cancer screening A colonoscopy performed to screen for colorectal cancer in individuals who are not at high risk for the disease. |
31 | $196 | $1,077 |
| Ultrasound scan of organ tissue for measuring elasticity This procedure uses ultrasound technology to assess the stiffness or elasticity of organ tissues. It helps evaluate tissue characteristics without invasive methods. |
14 | $86 | $340 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
14 | $54 | $245 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
94.0% high complexity
1.8% medium
4.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$198,703
Total received (2018-2024)
Avg $28,386/year across 7 years
Top 1% in FL for gastroenterology
60
Companies
1,052
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$164,509 (82.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$33,858 (17.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$336 (0.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$115,398
2023
$3,525
2022
$2,942
2021
$16,729
2020
$929
2019
$21,442
2018
$37,737
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Phathom Pharmaceuticals, Inc.
$95,416
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$46,253
Celltrion USA Inc.
$17,584
Takeda Pharmaceuticals U.S.A., Inc.
$10,237
Synergy Pharmaceuticals Inc
$9,112
Otsuka America Pharmaceutical, Inc.
$3,619
ABBVIE INC.
$2,739
Allergan Inc.
$1,480
AbbVie, Inc.
$1,268
E.R. Squibb & Sons, L.L.C.
$1,168
Janssen Biotech, Inc.
$961
AbbVie Inc.
$863
Celgene Corporation
$779
PFIZER INC.
$768
Ardelyx, Inc.
$496
Ferring Pharmaceuticals Inc.
$402
Romark Laboratories, LC
$402
Cumberland Pharmaceuticals, Inc.
$381
QOL Medical, LLC
$378
Gilead Sciences, Inc.
$325
Braintree Laboratories, Inc.
$323
GENZYME CORPORATION
$305
Shire North American Group Inc
$270
UCB, Inc.
$264
RedHill Biopharma Inc.
$219
Intercept Pharmaceuticals, Inc.
$214
Merck Sharp & Dohme Corporation
$214
Pharmacosmos Therapeutics Inc.
$194
Merck Sharp & Dohme LLC
$193
Ironwood Pharmaceuticals, Inc
$188
Medtronic, Inc.
$163
Lilly USA, LLC
$160
Nestle HealthCare Nutrition Inc.
$148
Daiichi Sankyo Inc.
$120
Regeneron Healthcare Solutions, Inc.
$110
Fresenius Kabi USA, LLC
$101
NESTLE HEALTHCARE NUTRITION INC.
$100
Janssen Scientific Affairs, LLC
$94
Prometheus Laboratories Inc.
$64
Ethicon Inc.
$58
Endo Pharmaceuticals Inc.
$55
Axonics, Inc.
$55
Shionogi Inc
$46
IRONWOOD PHARMACEUTICALS, INC
$42
INTERCEPT PHARMACEUTICALS, INC.
$41
AIMMUNE THERAPEUTICS, INC.
$40
Micro-tech Endoscopy USA, Inc.
$34
EVOKE PHARMA, INC.
$31
Madrigal Pharmaceuticals
$28
Amgen Inc.
$26
VIVUS, Inc.
$24
Alnylam Pharmaceuticals Inc.
$21
Boehringer Ingelheim Pharmaceuticals, Inc.
$20
Ethicon US, LLC
$18
Covidien LP
$16
Allergan, Inc.
$16
VIVUS LLC
$16
Evoke Pharma, Inc.
$14
Lucid Diagnostics Inc.
$14
GI Supply, Inc.
$12
Top 3 companies account for 80.1% of total payments
Associated products mentioned in payments ›
ABC · ALINIA · APRISO · AVSOLA · Alinia · Alinia Tablets 500mg 30 count bottle · Amitiza · Axonics · BREATHTEK · CIMZIA · CLENPIQ · CREON · Cimzia · Creon · DIFICID · DUPIXENT · Dexilant · ENTYVIO · EOHILIA · Entyvio · Epclusa · GATTEX · GIMOTI · GIVLAARI · HUMIRA · Humira · IBSRELA · IDACIO · INFLECTRA · INJECTAFER · INTERSTIM · KRISTALOSE · Kristalose · Kristalose 20gm · LINX Reflux Management System · LINZESS · Linzess · MAVYRET · MONOFERRIC · MOTEGRITY · MOTOFEN · Mavyret · Movantik · Mulpleta · NASCOBAL · OCALIVA · OMVOH · Omeclamox · Omeclamox-Pak · PANCREAZE · PLENVU · REBYOTA · RELISTOR · REMICADE · RESMETIROM · RINVOQ · SKYRIZI · STELARA · SUCRAID · SUPREP · SUPREP BOWEL PREP · SUTAB · Small Bowel · Sucraid · SureClip · Symproic · TREMFYA · TRULANCE · Talicia · Trulance · VEGZELMA · VELSIPITY · VIBERZI · VOQUEZNA · XELJANZ · XIFAXAN · XIFAXANIBSD · XIFIXAN · YUFLYMA · ZENPEP · ZEPATIER · ZEPOSIA · ZINPLAVA · ZYMFENTRA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (83%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in gastroenterology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for gastroenterology in FL.
Equivalent to $524 per 100 Medicare services performed
Geographic Context
Gastroenterologists within 10 mi
130
Per 100K population
8.6
County median income
$81,115
Nearest hospital
DELRAY MEDICAL CENTER
1.6 mi
1.6 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Naus is a mixed practice specialist, with above-average Medicare volume (top 0% in FL), with speaking/promotional industry engagement in the top 1% of FL peers, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Naus experienced with vedolizumab infusion (entyvio)?
Based on Medicare claims data, Dr. Naus performed 33,600 vedolizumab infusion (entyvio) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Naus receive payments from pharmaceutical companies?
Yes. Dr. Naus received a total of $198,703 from 60 companies across 1,052 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Naus's costs compare to other gastroenterologists in Delray Beach?
Dr. Naus's average Medicare payment per service is $23. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Naus) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Gastroenterology
Common procedures, typical costs, and what industry payments mean in gastroenterology.
Same specialty & city
Gastroenterologists in Delray Beach
Browse gastroenterologists in Delray Beach ranked by procedure volume and transparency data.
Highest volume
Top Gastroenterologists in FL
Gastroenterologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Gastroenterologists in FL
Which FL gastroenterologists receive the most from drug and device companies.
By company
Phathom Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Phathom Pharmaceuticals, Inc.
By company
Salix Pharmaceuticals, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Salix Pharmaceuticals, a division of Bausch Health US, LLC.
By company
Celltrion USA Inc. Payments to Doctors
See all physicians who received payments from Celltrion USA Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology